LYRA Lyra Therapeutics, Inc. Common Stock SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Best Medical Devices Stocks 2026 →

Lyra Therapeutics (LYRA) Stock: Buy, Sell, or Hold?

$0.50
-0.83 (-62.50%) ▼
5d: -61.92% 30d: -62.5% 90d: -87.62%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (76%)
Quality Score
44/100
Position
FAIR
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$16.00
+3132.3% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$1.08 / $1.42
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: LYRA is down 61.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When LYRA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: LYRA is currently trading at $0.49, which is considered fair based on recent price action.

Technical Outlook: Technically, LYRA is in a strong downtrend. The price is currently testing key support at $1.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 62.5% recently.

Market Sentiment: LYRA scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.00 (+3132.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 44/100 (HOLD)
Volume Confirmation UNKNOWN
Confidence Score 76.3%

Trading Range & Key Levels

Support Level $1.08
Resistance Level $1.42
Current Trend Strong Downtrend
Technical data as of Mar 16, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BEARISH: Downward momentum (-62.5%)
  • BULLISH: Trading 3132.3% below Wall St target ($16.00)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.07
Wall Street Target $16.00 (+3132.3%)
Revenue Growth (YoY) -87.2%
Share LYRA Analysis

Share this live LYRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (LYRA)

Bearish 4 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Mar 16, 2026
Daily AI digest
AI Retail Discussion Summary: Negative sentiment prevails on $LYRA as delisting and appeal rejection messages circulate on StockTwits, with no positive news articles to offset the bearish tone.
Key Retail Themes: Delisting Appeal Rejection
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 17, 2026 2:40 PM ET
Data refreshes hourly during market hours. Next update: 3:40 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for LYRA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$469 35 SELL
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$109 57 HOLD
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 34 SELL
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 38 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 44 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals